Abbott Probes Cyberattack on Cancer Diagnostics

Abbott Laboratories is currently investigating two cybersecurity incidents that recently compromised some internal systems. The first incident involved unauthorized access to systems within Abbott's cancer diagnostics business. The company has confirmed that no other businesses, sites, or systems were affected by this particular breach.

The second incident targeted the LabCentral portal, a third-party hosted platform used by Abbott's core laboratory diagnostics business. While unauthorized access occurred, Abbott stated that its businesses and customers remained unaffected. Crucially, no sensitive customer or business information was known to be exposed from the LabCentral portal, which contained only publicly available technical documents.

Abbott has engaged external cybersecurity experts and law enforcement agencies to thoroughly investigate both incidents and determine the extent of any accessed information. The company does not expect these cyber events to have a material impact on its overall business or financial performance. This situation follows a trend of increasing cyberattacks on healthcare companies.